Matches in Wikidata for { <http://www.wikidata.org/entity/Q65377327> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65377327 description "clinical trial" @default.
- Q65377327 description "ensayu clínicu" @default.
- Q65377327 description "klinisch onderzoek" @default.
- Q65377327 description "клінічне випробування" @default.
- Q65377327 name "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 name "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 type Item @default.
- Q65377327 label "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 label "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 prefLabel "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 prefLabel "Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 P1050 Q65377327-2645BA9A-DE6C-4A03-962F-CB2DB98AA378 @default.
- Q65377327 P1132 Q65377327-20CFBA7B-0C83-4F07-9382-A1F2C46FB5FC @default.
- Q65377327 P1476 Q65377327-DCE8056F-7CCA-4322-AAB3-975577E2296C @default.
- Q65377327 P17 Q65377327-D68D99F4-0749-4AEE-9C99-4863EC5947BC @default.
- Q65377327 P2899 Q65377327-CEB3BC02-180C-4805-919C-F00DD5BAACC7 @default.
- Q65377327 P3098 Q65377327-947144CF-9A8B-4B4E-A1D4-039A521AB30B @default.
- Q65377327 P31 Q65377327-80FEAAAC-E504-4FA5-B579-0B3EBF69A461 @default.
- Q65377327 P4135 Q65377327-A9A64EDC-454E-4D78-84DE-192D20DD8E01 @default.
- Q65377327 P580 Q65377327-E82A359C-50BA-4B46-B8D1-29FB914B2C0D @default.
- Q65377327 P582 Q65377327-4A49D06D-7356-464E-A4FA-7C1FE7DD3CA7 @default.
- Q65377327 P6099 Q65377327-579ACB05-FDE4-4828-AD36-56342643741F @default.
- Q65377327 P8363 Q65377327-9A44937E-49CE-4D58-974E-C791697B1CD1 @default.
- Q65377327 P1050 Q12206 @default.
- Q65377327 P1132 "+116" @default.
- Q65377327 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes" @default.
- Q65377327 P17 Q30 @default.
- Q65377327 P2899 "+35" @default.
- Q65377327 P3098 "NCT00831779" @default.
- Q65377327 P31 Q30612 @default.
- Q65377327 P4135 "+70" @default.
- Q65377327 P580 "2009-04-01T00:00:00Z" @default.
- Q65377327 P582 "2010-08-01T00:00:00Z" @default.
- Q65377327 P6099 Q42824440 @default.
- Q65377327 P8363 Q78089383 @default.